Skip to main content
Top
Published in: Lasers in Medical Science 6/2018

01-08-2018 | Original Article

Topically applied hypericin exhibits skin penetrability on nude mice

Authors: Zhuo-heng Li, Yuan-yuan Li, Min Hou, Tao Yang, Lai-chun Lu, Xiao-Yu Xu

Published in: Lasers in Medical Science | Issue 6/2018

Login to get access

Abstract

Hypericin, a powerful natural photosensitizer in photodynamic therapy (PDT), is suitable for treating skin diseases involving excess capillary proliferation. In the present study, we aimed to evaluate the skin penetrability of topically applied hypericin, expecting a reduced risk of prolonged skin photosensitivity, which often occurs after systemic administration. Firstly, the Franz diffusion cell assays were performed to evaluate the penetration effects of different enhancers, including menthol, propylene glycol, camphanone, azone, and carbamide. In view of above evaluation results, we selected menthol as the enhancer in the subsequent in vivo studies. The setting groups were as follows: the blank control group, the light-exposure control group, the gel-base control group, the hypericin gel group, and a hypericin gel-containing menthol group. Except for the blank control, all other animals were irradiated by a LED light. Then, fluorescence microscopy was performed to examine the distribution of hypericin in the skin of nude mouse. Macroscopic and microscopic analyses were also carried out to detect pathological changes in the skin after topical hypericin-PDT treatment. Immunohistochemistry was used to determine the expression change of PECAM-1. As shown in the results, menthol facilitated hypericin penetrate the skin of nude mice most. The results of in vivo assays revealed that hypericin penetrated nude mouse skin, spread to the dermis, and resulted in obvious photosensitivity reaction on the dermal capillaries. Moreover, skin injured by the photosensitive reaction induced by hypericin-PDT treatment was replaced by normal skin within 7 days. We concluded that topical applied hypericin could penetrate nude mouse skin well and has a great potential in PDT treatment of skin diseases.
Literature
3.
go back to reference Huygens A et al (2005) Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation. Int J Oncol 26(6):1691–1697 Huygens A et al (2005) Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation. Int J Oncol 26(6):1691–1697
4.
go back to reference Redmond RW, Gamlin JN (1999) A compilation of singlet oxygen yields from biologically relevant molecules. Photochem Photobiol 70(4):391–475CrossRefPubMed Redmond RW, Gamlin JN (1999) A compilation of singlet oxygen yields from biologically relevant molecules. Photochem Photobiol 70(4):391–475CrossRefPubMed
5.
go back to reference Vandenbogaerde AL et al (1997) Differential cytotoxic effects induced after photosensitization by hypericin. J Photochem Photobiol B Biol 38(2):136–142CrossRef Vandenbogaerde AL et al (1997) Differential cytotoxic effects induced after photosensitization by hypericin. J Photochem Photobiol B Biol 38(2):136–142CrossRef
6.
go back to reference Dewi NA et al (2008) Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area. Jpn J Ophthalmol 52(4):277–281CrossRefPubMed Dewi NA et al (2008) Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area. Jpn J Ophthalmol 52(4):277–281CrossRefPubMed
7.
go back to reference Quiney C et al (2006) Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia 20(4):583–589CrossRefPubMed Quiney C et al (2006) Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia 20(4):583–589CrossRefPubMed
8.
go back to reference Chen B et al (2001) Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93(2):275–282CrossRefPubMed Chen B et al (2001) Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93(2):275–282CrossRefPubMed
9.
go back to reference Agostinis P et al (2002) Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34(3):221–241CrossRefPubMed Agostinis P et al (2002) Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34(3):221–241CrossRefPubMed
10.
go back to reference Desheng M et al (2010) Effect of hypericin injection combined with 525-nm photodynamic therapy on port wine stains. Acta Acad Med Milit Tertiae 10:017 Desheng M et al (2010) Effect of hypericin injection combined with 525-nm photodynamic therapy on port wine stains. Acta Acad Med Milit Tertiae 10:017
11.
go back to reference Li Zh et al (2014) Hypericin damages the ectatic capillaries in a Roman cockscomb model and inhibits the growth of human endothelial cells more potently than hematoporphyrin does through induction of apoptosis. Photochem Photobiol 90(6):1368–1375CrossRefPubMed Li Zh et al (2014) Hypericin damages the ectatic capillaries in a Roman cockscomb model and inhibits the growth of human endothelial cells more potently than hematoporphyrin does through induction of apoptosis. Photochem Photobiol 90(6):1368–1375CrossRefPubMed
12.
go back to reference Mulliken JB (1988) Capillary (port-wine) and other telangiectatic stains. Vascular birthmarks, hemangiomas, and malformations. WB Saunders, Philadelphia Mulliken JB (1988) Capillary (port-wine) and other telangiectatic stains. Vascular birthmarks, hemangiomas, and malformations. WB Saunders, Philadelphia
13.
go back to reference Neumann R et al (1994) Immunohistochemistry of port-wine stains and normal skin with endothelium-specific antibodies PAL-E, anti-ICAM-1, anti-ELAM-1, and anti-factor VIIIrAg. Arch Dermatol 130(7):879–883CrossRefPubMed Neumann R et al (1994) Immunohistochemistry of port-wine stains and normal skin with endothelium-specific antibodies PAL-E, anti-ICAM-1, anti-ELAM-1, and anti-factor VIIIrAg. Arch Dermatol 130(7):879–883CrossRefPubMed
14.
go back to reference Barsky SH et al (1980) The nature and evolution of port wine stains: a computer-assisted study. J Investig Dermatol 74(3):154–157CrossRefPubMed Barsky SH et al (1980) The nature and evolution of port wine stains: a computer-assisted study. J Investig Dermatol 74(3):154–157CrossRefPubMed
15.
go back to reference GERONEMUS RG, Ashinoff R (1991) The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol 17(1):76–79CrossRefPubMed GERONEMUS RG, Ashinoff R (1991) The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol 17(1):76–79CrossRefPubMed
16.
go back to reference Lan J et al (1998) Changes of skin perfusion after photodynamic therapy for port wine stain. Chin Med J 111(2):138–138 Lan J et al (1998) Changes of skin perfusion after photodynamic therapy for port wine stain. Chin Med J 111(2):138–138
17.
go back to reference Ouyang T, Cheng Y, Xing X (1998) Clinical application of photodynamic therapy combined with non-coherent light (red light) for treatment of port-wine stains. Chin J Plast Surg Burns 14(3):163–165 Ouyang T, Cheng Y, Xing X (1998) Clinical application of photodynamic therapy combined with non-coherent light (red light) for treatment of port-wine stains. Chin J Plast Surg Burns 14(3):163–165
18.
go back to reference Wang Y et al (2010) Fluorescence monitoring of a photosensitizer and prediction of the therapeutic effect of photodynamic therapy for port wine stains. Exp Biol Med 235(2):175–180CrossRef Wang Y et al (2010) Fluorescence monitoring of a photosensitizer and prediction of the therapeutic effect of photodynamic therapy for port wine stains. Exp Biol Med 235(2):175–180CrossRef
19.
go back to reference Machado AHA et al (2008) Cytotoxicity of octal-bromide zinc phthalocyanine after photodynamic therapy with different light sources. Photomed Laser Surg 26(5):455–459CrossRefPubMed Machado AHA et al (2008) Cytotoxicity of octal-bromide zinc phthalocyanine after photodynamic therapy with different light sources. Photomed Laser Surg 26(5):455–459CrossRefPubMed
20.
go back to reference Braathen LR et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56(1):125–143CrossRefPubMed Braathen LR et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56(1):125–143CrossRefPubMed
21.
go back to reference Xiao-Xi L et al (1997) Treatment of capillary vascular malformation (port-wine stains) with photochemotherapy. Plast Reconstr Surg 99(7):1826–1830CrossRef Xiao-Xi L et al (1997) Treatment of capillary vascular malformation (port-wine stains) with photochemotherapy. Plast Reconstr Surg 99(7):1826–1830CrossRef
22.
go back to reference Nam SH et al (2011) Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. Int J Pharm 419(1–2):114–120CrossRefPubMed Nam SH et al (2011) Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. Int J Pharm 419(1–2):114–120CrossRefPubMed
23.
go back to reference Uzdensky AB et al (2003) Photodynamic effect of hypericin and a water-soluble derivative on isolated crayfish neuron and surrounding glial cells. J Photochem Photobiol B 72(1–3):27–33CrossRefPubMed Uzdensky AB et al (2003) Photodynamic effect of hypericin and a water-soluble derivative on isolated crayfish neuron and surrounding glial cells. J Photochem Photobiol B 72(1–3):27–33CrossRefPubMed
24.
25.
go back to reference Lavie G et al (1995) The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities. Med Res Rev 15(2):111–119CrossRefPubMed Lavie G et al (1995) The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities. Med Res Rev 15(2):111–119CrossRefPubMed
26.
go back to reference D'Hallewin MA et al (2000) Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164(2):349–351CrossRefPubMed D'Hallewin MA et al (2000) Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164(2):349–351CrossRefPubMed
27.
go back to reference Williams AC, Barry BW (2012) Penetration enhancers. Adv Drug Deliv Rev 64:128–137CrossRef Williams AC, Barry BW (2012) Penetration enhancers. Adv Drug Deliv Rev 64:128–137CrossRef
28.
go back to reference Babu RJ, Pandit JK (2005) Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv 12(3):165–169CrossRefPubMed Babu RJ, Pandit JK (2005) Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv 12(3):165–169CrossRefPubMed
29.
go back to reference Marjukka Suhonen T, Bouwstra JA, Urtti A (1999) Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release 59(2):149–161CrossRefPubMed Marjukka Suhonen T, Bouwstra JA, Urtti A (1999) Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release 59(2):149–161CrossRefPubMed
Metadata
Title
Topically applied hypericin exhibits skin penetrability on nude mice
Authors
Zhuo-heng Li
Yuan-yuan Li
Min Hou
Tao Yang
Lai-chun Lu
Xiao-Yu Xu
Publication date
01-08-2018
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 6/2018
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-018-2479-8

Other articles of this Issue 6/2018

Lasers in Medical Science 6/2018 Go to the issue